Avadel Pharmaceuticals Net Profit Margin 2006-2020 | AVDL

Avadel Pharmaceuticals net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Avadel Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.05B $0.02B 38.30%
2020-03-31 $0.06B $-0.02B -40.00%
2019-12-31 $0.06B $-0.03B -57.63%
2019-09-30 $0.07B $-0.10B -137.68%
2019-06-30 $0.08B $-0.10B -136.00%
2019-03-31 $0.09B $-0.10B -111.63%
2018-12-31 $0.10B $-0.10B -92.23%
2018-09-30 $0.12B $-0.04B -33.33%
2018-06-30 $0.14B $-0.00B -0.73%
2018-03-31 $0.15B $0.03B 20.13%
2017-12-31 $0.17B $0.07B 39.66%
2017-09-30 $0.18B $0.08B 45.05%
2017-06-30 $0.17B $0.04B 22.99%
2017-03-31 $0.17B $-0.01B -5.39%
2016-12-31 $0.15B $-0.04B -27.33%
2016-09-30 $0.15B $0.03B 20.00%
2016-06-30 $0.17B $0.02B 13.33%
2016-03-31 $0.18B $0.03B 14.29%
2015-12-31 $0.17B $0.04B 25.00%
2015-09-30 $0.13B $-0.06B -45.45%
2015-06-30 $0.09B $-0.04B -45.65%
2015-03-31 $0.05B $-0.05B -90.20%
2014-12-31 $0.03B $-0.09B -314.81%
2014-09-30 $0.03B $-0.05B -176.67%
2014-06-30 $0.03B $-0.05B -168.97%
2014-03-31 $0.03B $-0.06B -225.93%
2013-12-31 $0.02B $-0.04B -186.96%
2013-09-30 $0.02B $-0.04B -162.50%
2013-06-30 $0.02B $-0.04B -169.57%
2013-03-31 $0.02B $-0.01B -30.43%
2012-12-31 $0.03B $-0.00B -12.00%
2012-09-30 $0.03B $-0.01B -51.85%
2012-06-30 $0.03B $-0.01B -18.75%
2012-03-31 $0.03B $-0.01B -24.24%
2011-12-31 $0.03B $-0.01B -24.24%
2011-09-30 $0.04B $-0.00B -8.11%
2011-06-30 $0.04B $-0.01B -22.86%
2011-03-31 $0.04B $-0.01B -25.00%
2010-12-31 $0.04B $-0.01B -21.62%
2010-09-30 $0.04B $-0.02B -48.57%
2010-06-30 $0.04B $-0.02B -45.95%
2010-03-31 $0.04B $-0.02B -43.59%
2009-12-31 $0.04B $-0.01B -27.91%
2009-09-30 $0.04B $-0.01B -21.95%
2009-06-30 $0.04B $-0.01B -20.00%
2009-03-31 $0.04B $-0.01B -17.95%
2008-12-31 $0.04B $-0.01B -31.58%
2008-09-30 $0.04B $-0.01B -35.00%
2008-06-30 $0.04B $-0.02B -52.50%
2008-03-31 $0.04B $-0.03B -84.21%
2007-12-31 $0.04B $-0.04B -100.00%
2007-09-30 $0.03B $-0.04B -111.76%
2007-06-30 $0.03B $-0.04B -130.00%
2007-03-31 $0.03B $-0.03B -121.43%
2006-12-31 $0.02B $-0.04B -152.17%
2006-09-30 $0.02B $-0.04B -166.67%
2006-06-30 $0.02B $-0.04B -194.74%
2006-03-31 $0.02B $-0.04B -185.00%
2005-12-31 $0.02B $-0.03B -117.39%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.312B $0.059B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.018B 43.24
Takeda Pharmaceutical (TAK) Japan $52.809B 9.20
Astellas Pharma (ALPMY) Japan $26.084B 0.00
Eisai (ESALY) Japan $24.422B 20.64
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $18.921B 24.81
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $15.013B 48.80
Grifols, S.A (GRFS) Spain $13.105B 16.02
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 24.00
Neurocrine Biosciences (NBIX) United States $9.390B 36.35
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.481B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.192B 13.55
IPSEN SA ADR (IPSEY) France $7.744B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.594B 41.77
Orion OYJ (ORINY) Finland $6.484B 22.50
United Therapeutics (UTHR) United States $5.173B 11.96
Arrowhead Pharmaceuticals (ARWR) United States $5.123B 0.00
FibroGen (FGEN) United States $4.135B 0.00
Evotec AG (EVTCY) Germany $4.120B 143.03
ChemoCentryx (CCXI) United States $3.696B 0.00
Sage Therapeutics (SAGE) United States $3.624B 0.00
PTC Therapeutics (PTCT) United States $3.527B 0.00
Hypermarcas (HYPMY) Brazil $3.389B 12.47
Nektar Therapeutics (NKTR) United States $3.018B 0.00
Revolution Medicines (RVMD) United States $2.947B 0.00
Pacira BioSciences (PCRX) United States $2.337B 61.43
Xencor (XNCR) United States $2.294B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.265B 10.97
Corcept Therapeutics (CORT) United States $2.045B 18.83
Cronos Group (CRON) Canada $2.012B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.970B 0.00
USANA Health Sciences (USNA) United States $1.630B 15.35
Ironwood Pharmaceuticals (IRWD) United States $1.579B 10.97
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.552B 14.80
Trillium Therapeutics (TRIL) Canada $1.412B 0.00
Heron Therapeutics (HRTX) United States $1.376B 0.00
Endo (ENDP) Ireland $1.296B 1.92
Theravance Biopharma (TBPH) Cayman Islands $1.195B 0.00
Translate Bio (TBIO) United States $1.126B 0.00
Karyopharm Therapeutics (KPTI) United States $1.123B 0.00
Zogenix (ZGNX) United States $1.119B 0.00
Indivior (INVVY) United States $1.053B 13.06
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
ImmunoGen (IMGN) United States $0.986B 0.00
Esperion Therapeutics (ESPR) United States $0.945B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.873B 543.88
Vectura Group (VEGPF) United Kingdom $0.828B 0.00
Tilray (TLRY) Canada $0.824B 0.00
Ocular Therapeutix (OCUL) United States $0.731B 0.00
Collegium Pharmaceutical (COLL) United States $0.704B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.662B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.651B 32.49
Flexion Therapeutics (FLXN) United States $0.645B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.629B 0.00
VAXART, INC (VXRT) United States $0.621B 0.00
Radius Health (RDUS) United States $0.619B 0.00
Molecular Templates (MTEM) United States $0.553B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.551B 0.00
Siga Technologies (SIGA) United States $0.531B 56.67
Akebia Therapeutics (AKBA) United States $0.530B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.523B 0.00
Ardelyx (ARDX) United States $0.489B 0.00
Aerie Pharmaceuticals (AERI) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.439B 0.00
TherapeuticsMD (TXMD) United States $0.438B 0.00
Organogenesis Holdings (ORGO) United States $0.434B 0.00
Altimmune (ALT) United States $0.401B 0.00
Harpoon Therapeutics (HARP) United States $0.396B 0.00
Redhill Biopharma (RDHL) Israel $0.388B 0.00
DURECT (DRRX) United States $0.363B 0.00
Profound Medical (PROF) Canada $0.342B 0.00
Concert Pharmaceuticals (CNCE) United States $0.342B 0.00
Jounce Therapeutics (JNCE) United States $0.338B 16.00
Catalyst Pharmaceuticals (CPRX) United States $0.336B 8.33
MEI Pharma (MEIP) United States $0.330B 0.00
Menlo Therapeutics (VYNE) United States $0.324B 0.00
Innate Pharma SA (IPHYF) France $0.313B 0.00
Calithera Biosciences (CALA) United States $0.289B 0.00
Lannett Co Inc (LCI) United States $0.280B 6.50
KalVista Pharmaceuticals (KALV) United States $0.276B 0.00
Rafael Holdings (RFL) United States $0.267B 0.00
Aduro Biotech (KDNY) United States $0.262B 0.00
Xeris Pharmaceuticals (XERS) United States $0.255B 0.00
CTI BioPharma (CTIC) United States $0.243B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
IMV INC (IMV) Canada $0.240B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.233B 0.00
Nature's Sunshine Products (NATR) United States $0.224B 22.04
CASI Pharmaceuticals (CASI) United States $0.205B 0.00
Nivalis Therapeutics (ALPN) United States $0.202B 0.00
Aclaris Therapeutics (ACRS) United States $0.193B 0.00
Heat Biologics (HTBX) United States $0.186B 0.00
Otonomy (OTIC) United States $0.183B 0.00
OptiNose (OPTN) United States $0.181B 0.00
Aquestive Therapeutics (AQST) United States $0.181B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.179B 0.00
Taiwan Liposome (TLC) Taiwan $0.177B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.169B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.160B 0.00
Champions Oncology (CSBR) United States $0.118B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.110B 0.00
MediWound (MDWD) Israel $0.101B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Hemispherx BioPharma (AIM) United States $0.090B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.082B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.078B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.078B 0.00
ElectroCore (ECOR) United States $0.077B 0.00
Novan (NOVN) United States $0.077B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Biomerica (BMRA) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.00
CV Sciences (CVSI) United States $0.053B 0.00
Natural Alternatives (NAII) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.051B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.051B 0.00
Recro Pharma (REPH) United States $0.050B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.00
PolarityTE (PTE) United States $0.039B 0.00
IsoRay (ISR) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.86
GTx (ONCT) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.033B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Vical (BBI) United States $0.028B 0.00
Neos Therapeutics (NEOS) United States $0.026B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
Sundial Growers (SNDL) Canada $0.020B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 27.36
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.015B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
JanOne (JAN) United States $0.009B 0.00
Shineco (TYHT) China $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00